Dr Paul Anderson’s Presentation on Thyroid Disorders at The 2017 LDN Conference

In this presentation Dr Paul Anderson, from Seattle Washington, discusses the use of Low Dose Naltrexone immunotherapy in thyroid conditions.

Dr Anderson covers a description of the common thyroid conditions.  He outlines the immune effects aggravating these conditions, the effects in clinical practice of immune and hormonal therapies on thyroid conditions and the latest use and implementation of immunotherapies in thyroid conditions. 

Dr Anderson uses his background with thousands of doses of Low Dose Naltrexone (LDN) to connect the newest data with clinical practicalities in the use of LDN. 

This presentation’s learning objectives are to:

Describe the frequency and variety of thyroid disorders in humans.  

Discuss the immunologic basis for these conditions. 

Relate the manner in which thyroid therapy needs to be “More than hormonal” to achieve best outcomes. 

Discuss the latest immunologic agents available for these conditions - which of course includes Low Dose Naltrexone.  

Thank you for listening.  For more presentations please visit www.ldnresearchtrust.org/ldn-conferences